Disney
DIS
Alibaba
BABA
Apple
AAPL
4
Adobe
ADBE
5
Netflix
NFLX
US Stock MarketDetailed Quotes
ENSC Ensysce Biosciences
- 1.760
- -0.120-6.38%
Close Apr 17 16:00 ET
- 1.790
- +0.030+1.70%
Post 20:01 ET
2.89MMarket Cap-0.30P/E (TTM)
1.820High1.710Low133.33KVolume1.800Open1.880Pre Close233.56KTurnover11.74%Turnover RatioLossP/E (Static)1.64MShares14.67052wk High0.78P/B2.00MFloat Cap1.70052wk Low--Dividend TTM1.14MShs Float86364.000Historical High--Div YieldTTM5.85%Amplitude1.700Historical Low1.751Avg Price1Lot Size
About Ensysce Biosciences Company
Ensysce Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of solutions for severe pain relief while reducing the fear of and the potential for misuse and overdose. The firm's Trypsin Activated Abuse Protection and Multi-Pill Abuse Resistance platforms are in the process of developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. The company was founded in April 2003 and is headquartered in La Jolla, CA.
Company Profile
SymbolENSC
Company NameEnsysce Biosciences
Listing DateDec 29, 2017
Founded2003
CEODr. D. Lynn Kirkpatrick, PhD
MarketNASDAQ
Employees9
Fiscal Year Ends12-31
Address7946 Ivanhoe Avenue,Suite 201
CityLa Jolla
ProvinceCalifornia
CountryUnited States of America
Zip Code92037
Phone1-858-263-4196
Websitehttp://www.ensysce.com
Company Executives
- Name
- Position
- Salary
- Dr. D. Lynn Kirkpatrick, PhD
- President, Chief Executive Officer and Director
- 508.58K
- Linda Pestano, PhD
- Chief Development Officer
- --
- Geoffrey Birkett
- Chief Commercial Officer
- 392.35K
- David Humphrey, C.P.A.
- Chief Financial Officer, Principal Accounting Officer, Secretary and Treasurer
- 441.95K
- Dr. William K. Schmidt, PhD
- Chief Medical Officer
- --
- Dr. Jeffrey Millard, PhD
- Chief Operating Officer
- --
- Dr. Bob G. Gower, PhD
- Chairman of the Board
- 47.60K
- Lee Rauch
- Independent Director
- 29.17K
- William Chang
- Independent Director
- 30.10K
- Steve R. Martin
- Independent Director
- 32.92K
- Andrew Benton, J.D.
- Independent Director
- 30.10K
- Dr. Curtis Rosebraugh, M.D.
- Independent Director
- 25.42K
- Dr. Adam S. Levin, M.D.
- Independent Director
- 27.92K
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀